Patents by Inventor Kishore Kalidas Rana

Kishore Kalidas Rana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
    Patent number: 8492375
    Abstract: The present invention relates to novel diazepanyl derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: July 23, 2013
    Assignee: Glaxo Group Limited
    Inventors: Gordon Bruton, Anthony Huxley, Barry Sidney Orlek, Kishore Kalidas Rana
  • 1-BENZOYL SUBSTITUTED DIAZEPINE DERIVATIVES AS SELECTIVE HISTAMINE H3 RECEPTOR AGONISTS
    Publication number: 20110039833
    Abstract: The present invention relates to novel diazepanyl derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Application
    Filed: October 26, 2010
    Publication date: February 17, 2011
    Inventors: GORDON BRUTON, Anthony Huxley, Barry Sidney Orlek, Kishore Kalidas Rana
  • 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
    Patent number: 7846922
    Abstract: The present invention relates to novel diazepanyl derivatives of formula (I) having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Grant
    Filed: October 14, 2004
    Date of Patent: December 7, 2010
    Assignee: Glaxo Group Limited
    Inventors: Gordon Bruton, Anthony Huxley, Barry Sidney Orlek, Kishore Kalidas Rana
  • Piperazine derivates and their use for the treatment of neurological and psychiatric diseases
    Patent number: 7592347
    Abstract: The present invention relates to novel piperidine carbonyl piperazine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: September 22, 2009
    Assignee: Glaxo Group Limited
    Inventors: Gordon Bruton, Barry Sidney Orlek, Kishore Kalidas Rana
  • 1-Benzoyl Substituted Diazepine Derivatives As Selective Histamine H3 Receptor Agonists
    Publication number: 20080045505
    Abstract: The present invention relates to novel diazepanyl derivatives of formula (I) having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Application
    Filed: October 14, 2004
    Publication date: February 21, 2008
    Inventors: Gordon Bruton, Anthony Huxley, Barry Sidney Orlek, Kishore Kalidas Rana
  • (Hetero) bicyclymethanesulfonylamino-substituted hydroxamic acid derivates
    Publication number: 20040225006
    Abstract: Compounds of formula (I) wherein R is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl; and R1 is bicyclyl or heterobicyclyl; are useful in the treatment and prophylaxis of conditions mediated by s-CD23 or TNF.
    Type: Application
    Filed: May 14, 2004
    Publication date: November 11, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Gordon Bruton, Andrew Faller, Barry Sidney Orlek, Kishore Kalidas Rana, Graham Walker
  • (Hetero) Bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives
    Publication number: 20030199571
    Abstract: Compounds of formula (I) wherein R is hydrogen, alkyl alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl; and R1 is bicyclyl or heterobicyclyl; are useful in the treatment and prophylaxis of conditions mediated by s-CD23 or TNF.
    Type: Application
    Filed: March 24, 2003
    Publication date: October 23, 2003
    Inventors: Gordon Bruton, Andrew Faller, Barry Sidney Orlek, Kishore Kalidas Rana, Graham Walker
  • Novel cd23 inhibitors
    Publication number: 20030134880
    Abstract: Compounds of formula (I) wherein R is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl; R1 is bicyclyl or heterobicyclyl; R2 is aryl, heteroaryl, heterocyclyl, alkoxy, alkyl, hydroxy or optionally substituted amino and n is from 0 to 3; with the provisos than when n is 0 R2 is alkyl or when n is from 1 to 3 R2 is not alkyl, are useful in the treatment and prophylaxis of conditions mediated by CD23 or TNF.
    Type: Application
    Filed: October 25, 2002
    Publication date: July 17, 2003
    Inventors: Gordon Bruton, Barry Sidney Orlek, Kishore Kalidas Rana